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Antimicrobial resistance and the emergence of multidrug- resistant 
bacteria are global problems that are predicted to cause ten million 
deaths per year by 2050 (ONeill, 2014). One alternative strategy to 
antibiotics is phage therapy: the use of parasitic viruses that spe-
cifically infect and kill certain bacterial pathogens. Compared to 
antibiotics, phage therapy is more targeted, leaving the beneficial 
or commensal microbiota unharmed (Skurnik, Pajunen, & Kiljunen, 
2007), self- replicating at the target site during the course of an 
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Antimicrobial resistance has been estimated to be responsible for over 700,000 
deaths per year; therefore, new antimicrobial therapies are urgently needed. One 
way to increase the efficiency of antibiotics is to use them in combination with 
bacteria- specific parasitic viruses, phages, which have been shown to exert additive 
or synergistic effects in controlling bacteria. However, it is still unclear to what extent 
these combinatory effects are limited by rapid evolution of resistance, especially 
when the pathogen grows as biofilm on surfaces typical for many persistent and 
chronic infections. To study this, we used a microcosm system, where genetically 
isogenic populations of Pseudomonas aeruginosa PAO1 bacterial pathogen were ex-
posed to a phage 14/1, gentamycin or a combination of them both in a spatially struc-
tured environment. We found that even though antibiotic and phageantibiotic 
treatments were equally effective at controlling bacteria in the beginning of the ex-
periment, combination treatment rapidly lost its efficacy in both planktonic and bio-
film populations. In a mechanistic manner, this was due to rapid resistance evolution: 
While both antibiotic and phage selected for increased resistance on their own, 
phage selection correlated positively with increase in antibiotic resistance, while bio-
film growth, which provided generalized resistance mechanism, was favoured most 
in the combination treatment. Only relatively small cost of resistance and weak evi-
dence for coevolutionary dynamics were observed. Together, these results suggest 
that spatial heterogeneity can promote rapid evolution of generalized resistance 
mechanisms without corresponding increase in phage infectivity, which could poten-
tially limit the effectiveness of phageantibiotic treatments in the evolutionary 
timescale.
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infection (Carlton, 1999), efficient against antibiotic- resistant bac-
teria (Kutter et al., 2010) and has low inherent toxicity to humans 
(Abedon & Thomas- Abedon, 2010). Furthermore, phages have the 
distinct advantage of being able to evolve with the bacteria to regain 
infectiveness via a coevolutionary arms race (Betts, Vasse, Kaltz, 
& Hochberg, 2013; Friman et al., 2016; Scanlan, Buckling, & Hall, 
2015).
Instead of replacing antibiotics, phage therapy could be used to 
complement antimicrobial therapeutic strategies (Torres- Barceló & 
Hochberg, 2016). A growing body of evidence suggests that com-
binations of phages and antibiotics are more effective at controlling 
pathogenic bacteria than either treatment alone due to additive 
effects or phageantibiotic synergy (PAS). Additive effects are ex-
pected when phage and antibiotic work independently of each other, 
and their combined effect is the sum of their independent effects. 
In the case of synergistic effects, phageantibiotic combinations 
are often observed to have more detrimental (or less detrimental) 
effects on the pathogenic bacteria than would be expected based 
on the sum of their independent effects (Comeau, Tétart, Trojet, 
Prère, & Krisch, 2007; Hagens, Habel, & Blasi, 2006; Huff, Huff, 
Rath, Balog, & Donoghue, 2004). PAS is thought to occur because 
two sufficiently different selective pressures are more likely to kill 
both nonresistant (susceptible to antibiotics) and antibiotic- resistant 
(susceptible to phages) pathogen genotypes (Torres- Barceló & 
o1_0;u]ķƑƏƐѵőĺou;o;uķ|o1om1uu;m|Ѵ-1|bm]v;Ѵ;1|bomru;v-
sures might impose evolutionary trade- offs for the pathogen, which 
could constrain the evolution of resistance to antibiotics, phage or 
both (Chan et al., 2016; Torres- Barceló & Hochberg, 2016; Wang 
et al., 2017). Here, we studied this using a model system where 
we exposed P. aeruginosa pathogen to both phage and sublethal 
concentration of gentamycin and monitored ecological and evolu-
tionary dynamics in both homogenous (planktonic) and spatial (bio-
film) dimensions of the microcosms. In particular, we explored how 
phageantibiotic combination affects the evolution of resistance 
mechanisms and how this process depends on the spatial structure 
of the environment typical for clinical infections.
The evolutionary responses to phageantibiotic combinations 
could be explained mechanistically by population density effects, 
collateral sensitivity or by high costs of adaptation. First, if phage
antibiotic combination is able to reduce pathogen densities more 
clearly compared to single- therapy treatments, it might limit the 
emergence of resistance mutations to either therapeutic agent via 
Ѵo;u;7 l|-|bom vrrѴ u-|;ĺ ou;o;uķ -m|b0bo|b1v -m7 r_-];v
could be applied sequentially, which could limit the emergence of 
double- resistant mutants if both antimicrobial agents are able to 
eliminate pathogen genotypes that are resistant to the other antimi-
crobial, that is, if phages can kill antibiotic- resistant bacteria and vice 
versa. Second, it is possible that evolution of resistance to one an-
timicrobial agent leads to collateral sensitivity to another antimicro-
bial agent (Imamovic & Sommer, 2013). For example, a Pseudomonas 
aeruginosa- specific phage has been reported to use outer membrane 
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the structure of these receptors has been shown to confer P. aerugi-
nosa resistance to phages, but at the same time increase its suscepti-
bility to antibiotics due to its less functional efflux pump (Chan et al., 
2016). In the same way, it has recently been reported that phage se-
lection can make Ralstonia solanacearum plant pathogenic bacterium 
more susceptible to antibiotics produced by Bacillus amyloliquefaciens 
biocontrol bacterium even though the mechanism has not yet been 
described in detail (Wang et al., 2017). Third, selection by phages 
and antibiotics could lead to increased costs of resistance, which 
could limit bacterial growth and infectiveness (Andersson & Hughes, 
ƑƏƐƏĸ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this, it has been shown that phage selection can reduce P. aeruginosa 
and R. solanacearum growth and potential competitive ability most 
when bacteria evolved in the presence of both phage and antibiot-
ics (Torres- Barceló, Franzon, Vasse, & Hochberg, 2016; Wang et al., 
2017), while phage resistance mutations have been shown to impair 
genes that are used for virulence leading to weaker infections (Addy, 
Askora, Kawasaki, Fujie, & Yamada, 2012; Chaturongakul & Ounjai, 
2014; Torres- Barceló et al., 2016).
Thus far, phageantibiotic combinations have predominantly 
been studied in relatively homogenous laboratory environments. 
Within- host environments are however often spatially heteroge-
neous (Costerton, Stewart, & Greenberg, 1999) allowing pathogens 
to grow as a biofilmadhered to various surfaces and embedded in 
a protective matrix of extracellular polysaccharides, proteins and 
DNA. Biofilms are also prevalent and persistent in clinical settings 
and have been found to form on clinical equipment such as catheters 
(Trautner & Darouiche, 2010), intravenous lines (Percival, Suleman, 
& Donelli, 2015) and prosthetic heart valves (Donlan & Costerton, 
2002). Biofilms typically have much higher antibiotic resistance 
than their planktonic counterparts (Stewart & Costerton, 2001), and 
there are multiple hypotheses for why this occurs. One explanation 
is that biofilm acts as a diffusion barrier preventing the penetration 
of antibiotics (de Beer, 1997). It has also been suggested that biofilms 
allow the persistence of pathogen subpopulations that can repopu-
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& Stewart, 2000). Third, the chemical microenvironment within the 
biofilm with zones of nutrient and oxygen depletion or waste ac-
cumulation could prevent the optimal functioning of antibiotics (de 
Beer, Stoodley, Roe, & Lewandowski, 1994). For example, some anti-
biotics target only actively growing bacteria and are thus ineffective 
against slowly reproducing bacteria within a nutrient- and oxygen- 
depleted biofilm (Tuomanen, Cozens, Tosch, Zak, & Tomasz, 1986).
Biofilm formation has also been shown to be an effective gen-
eral resistance mechanism against phages (Stewart & Costerton, 
2001; Vidakovic, Singh, Hartmann, Nadell, & Drescher, 2018). 
Similar to antibiotics, extracellular polysaccharides and proteins 
could prevent phage adsorption to its receptors while metaboli-
cally less active cells are less likely to get infected (Abedon, 2017; 
-0ub;ķ"-lvomķşobm;-ķƑƏƐƏőĺo;;uķ1;u|-bmr_-];v_-;
the ability to produce enzymes, which can degrade the extracel-
lular polymeric matrix (Hanlon, Denyer, Olliff, & Ibrahim, 2001; 
Hughes, Sutherland, Jones, & Rutherford, 1998), while other 
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phages are able to propagate radially through a biofilm (Doolittle, 
Cooney, & Caldwell, 1996). Surprisingly, little is currently known 
about phageantibiotic effects in biofilms. So far, it has been re-
ported that treating Klebsiella pneumoniae infections with a com-
bination of phage and antibiotic is more successful at limiting the 
emergence of phage- resistant pathogen mutants compared to an-
tibiotic alone, even though no difference was observed in the ef-
fectiveness to eradicate biofilms (Verma, Harjai, & Chhibber, 2009). 
Another study found that phageantibiotic combinations were 
more efficient at eradicating the planktonic and biofilm popula-
tions of multiple P. aeruginosa strains compared to antibiotic- alone 
treatments, but the evolution of resistance was not measured in 
this study (Nouraldin, Baddour, Harfoush, & Essa, 2016). Of late, 
it was shown that phageantibiotic combinations can consider-
ably vary in their efficiency to eradicate P. aeruginosa biofilms de-
pending on the specific phage species and the class of antibiotic 
(Chaudhry et al., 2017). However, there are no studies addressing 
the efficiency of phageantibiotic combinations on both plank-
tonic and biofilm populations of pathogenic bacteria in long- term 
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at phage coevolution during phageantibiotic treatments.
Here, we used an experimental evolution approach to study 
the effects of phageantibiotic combinations on Pseudomonas 
aeruginosa population density dynamics and resistance evolution. 
Pseudomonas aeruginosa is a Gram- negative, opportunistic bacte-
rial pathogen that readily forms biofilms. It is considered to be a 
leading source of nosocomial infections and is commonly linked 
with chronic diseases such as cystic fibrosis, where it is a major 
cause of morbidity and mortality (J. C. Davies, 2002). Pseudomonas 
aeruginosa infections are often difficult to treat because of low 
antibiotic susceptibility and the emergence of multidrug- resistant 
strains (Lister, Wolter, & Hanson, 2009). We set up four treatments 
where we evolved P. aeruginosa in the presence of gentamycin, 
phage 14/1 or both for 15 days under highly controlled labora-
tory conditions (N = 5). In order to study changes in both plank-
tonic and biofilm populations, all microcosms were seeded with 25 
glass beads to allow destructive sampling and isolation of biofilm 
bacterial populations (one bead per treatment replicate at every 
sampling time point, i.e., every third day). In addition to measuring 
phage and bacterial population density dynamics, we quantified 
changes in pathogen resistance to antibiotics and phages, associ-
ated costs of resistance and phagebacteria coevolutionary dy-
namics during the experiment.
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Pseudomonas aeruginosa PAO1 was used as a bacterial pathogen in 
this study. Isogenic starting stocks were cultured from a frozen an-
cestral stock in Lysogeny broth (LB) media and spread on LB agar 
plates. A single colony was chosen and used as a starting culture in 
the selection experiment. Phage 14/1 (Table 1) was used as a specific 
P. aeruginosa lytic phage. Phage stock solutions were prepared by 
growing frozen phages with PAO1 in LB media at 37°C for 24 hr with 
shaking at 200 rpm. To purify phages from bacteria, 10% (v/v) chlo-
roform was added and cultures vortexed and centrifuged at 11,000× 
g for 5 min. Phage stocks were stored at 4°C.
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Four evolutionary treatments were established with five replicate 
microcosms per treatment. Treatments included P. aeruginosa evolv-
ing alone (control), in the presence of gentamycin antibiotic, in the 
presence of phage 14/1 or evolving in the presence of both phage 
and antibiotic (combination treatment) (Supporting information 
Figure S1). We used 30 ml glass universals as microcosms that con-
tained 6 ml of LB and 25 submerged glass beads (VWR). Previous 
research has shown that biofilms can form on the outside of plas-
tic beads and can be successfully isolated using bath sonication 
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method was modified with 4- mm- diameter glass beads as a scaf-
fold for biofilms to form on. The bead biofilm model allowed us to 
destructively sample individual beads throughout the evolutionary 
experiment and study the effects of phage and antibiotic selection 
on biofilm populations separately.
All microcosms were initially inoculated with approximately 109 
cells/ml of isogenic stocks of PAO1. Phage treatments were fur-
ther inoculated with approximately 104 particles/ml of lytic phage 
14/1. Antibiotic treatments contained 3 μg/ml of gentamycin in LB, 
which was tested and deemed as a sublethal concentration of the 
broad- spectrum aminoglycoside antibiotic (Supporting informa-
tion Figure S2). It was also found that gentamycin and phage 14/1 
had additive effects over a 24- hr growth period: Bacteria grown 
for 24 hr had lower densities at higher concentrations of genta-
mycin (antibiotic concentration: F7, 48 = 255.111, p < 0.001), and 
the addition of phage 14/1 additively reduced bacterial densities 
$ ƐՊStrains used in this studya
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Bacteria PAO1 Clinical, nonrespiratory, 
Australia
1954 - - Pseudomonas 6,264
Phage 14/1 Sewage water, 
Regensburg, Germany
2000 obub7-;ĸƐ E serogroup Pb1- like virus 66
Note.aSource and genome size are given according to Friman et al. & Stover et al. (Friman et al., 2016; Stover et al., 2000); morphotype and serological 
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(phage: F1, 48 = 908.178, p < 0.001; phage × antibiotic concentration: 
F7, 48 = 19.222, p < 0.001; Supporting information Figure S2). In par-
ticular, the effect of phage was not significantly different at 0 and 
3 μg/ml of gentamycin, which is indicative of additive effects instead 
of phageantibiotic synergy (Supporting information Figure S2).
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in fed- batch culture throughout the experiment, where the volume 
of removed sample (83% of total volume) was replaced with fresh 
media (LB or LB with 3 μg/ml gentamycin), minimizing disruption to 
the biofilm. It was experimentally confirmed that 3 μg/ml gentamy-
cin in LB remained effective at reducing bacterial density after 72 hr 
at 37°C (antibiotic: tƷƴƑƕĺƐķdf = 22, p < 0.001; Supporting informa-
tion Figure S3). Therefore, microcosms were grown over 15 days, 
with sampling every 72 hr, which equals approximately 300 bacterial 
generations. At every sampling, a total of 5 ml of media was removed 
aseptically from each microcosm along with one randomly selected 
glass bead that was covered in biofilm (with sterilized forceps).
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Bacterial densities of planktonic and biofilm bacteria were meas-
ured throughout the experiment as colony- forming units (CFU/ml). 
Planktonic bacterial population densities were measured by diluting 
and plating subsets of collected aquatic samples at every sampling 
time point. To measure changes in biofilm bacterial population densi-
ties, biofilm colonies were isolated from glass beads from each rep-
licate population using a previously developed method (Popat et al., 
2012). In brief, biofilm cells were collected by aseptically retrieving 
a glass bead from each tube, gently washing it three times in 5 ml 
phosphate buffered saline (PBS) using five inversions and transfer-
ring to 1 ml fresh PBS. The washed beads were then sonicated in a 
bath sonicator for 10 min and vortexed for 20 s. Recovered biofilm 
populations were diluted and plated on LB agar plates to measure 
colony- forming units (CFU) per bead.
To estimate total biofilm population densities per microcosm, 
CFU count obtained from one individual bead was multiplied with 
the number of total beads present in the microcosm at given time 
point (removed beads were not replaced with new beads during the 
experiment). Biofilm population densities were normalized similarly 
with each replicate population, and the Figure 1b shows the mean 
of total biofilm densities. Total bacterial population densities per mi-
crocosm were then determined as a sum of CFU of planktonic and 
biofilm populations per replicate population for every sampling time 
point. To measure changes in bacterial fitness and resistance over 
time (see description below), 12 colonies per replicate population 
were randomly isolated at every time point from both planktonic and 
biofilm population samples from each microcosm. All the isolated 
colonies were grown on 96- well microplates overnight at 37°C in LB 
l;7b--m7=uo;m-|ƴѶƏŦbmƑƏѷŐņő]Ѵ1;uoѴĺ
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To measure phage population densities and changes in phage infec-
tivity and bacterial resistance over time, phage populations were 
isolated at every sampling point alongside bacteria. Phages were 
sampled from the liquid media and extracted using 10% (v/v) chlo-
roform, vortexing and centrifugation at 11,000 × g for 5 min. The 
densities of phages retained in the supernatant were determined as 
plaque- forming units (PFU/ml) using serial dilutions of phage sus-
pension and the agar overlay method (Adams, 1959). In brief, cul-
tures of phage- sensitive ancestral PAO1 strain were grown for 24 hr 
at 37°C with shaking at 200 rpm, after 100 μl of PAO1 culture was 
added to 10 ml molten overlay agar and mixed by inversion. PAO1- 
soft agar mixture was plated onto square Petri dishes on top of a 
F I G U R E  1ՊBacterial and phage 
densities during the selection experiment. 
Panel (a) denotes planktonic bacterial 
densities (CFU/ml); panel (b) denotes 
total biofilm bacterial densities (CFU/ml; 
standardized with the total number of 
beads per microcosm); panel (c) denotes 
total bacterial densities (CFU/ml; sum of 
total planktonic and biofilm populations), 
and panel (d) denotes phage densities 
(PFU/ml). Different line colours refer to 
antibiotic- only (red), phage- only (green), 
combination (purple) and control (blue) 
treatments. Error bars show ±1 standard 
error of mean
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layer of LB agar, and then, 5 μl of each phage dilution was pipetted 
onto the plate (totalling 48 dilutions per plate). Once dried, plates 
were incubated at 37°C for 24 hr and phage plaques were counted 
to ascertain phage concentration in PFU/ml.
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Antibiotic resistance assays were conducted using the clones iso-
lated in the end of the experiment. To this end, frozen plates of 
evolved biofilm and planktonic bacteria were fully thawed and rep-
licated into 96- well microplates with fresh LB using a pin replicator 
(~0.2 μl transfer per pin, Boekel). All evolved colonies were grown 
for 24 hr at 37°C after all bacterial isolates were replicated into fresh 
96- well plates containing LB with 3 μg/ml gentamycin. Bacterial 
isolates were further incubated for 24 hr at 37°C after which the 
growth was determined as optical density (OD600 nm, Tecan Infinite 
200). Antibiotic resistance was determined as the bacterial growth 
in the presence of 3 μg/ml gentamycin relative to bacterial growth 
in the absence of gentamycin. Larger difference thus denotes for 
antibiotic resistance (growth data shown in Supporting information 
Figure S4).
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Phage resistance assays were conducted using the clones isolated in 
the end of the experiment. Evolved bacterial isolates were thawed 
and replicated into 96- well plates containing LB media and inocu-
lated with approximately 102 particles of ancestral phage 14/1. After 
24 hr of incubation at 37°C, phage resistance was measured in terms 
of optical density (OD600 nm) where higher growth of evolved bac-
teria in the presence of phage relative to density of bacteria grown 
without phage denotes the evolution of phage resistance (growth 
data shown in Supporting information Figure S4). Phage resistance 
was also measured every second time point throughout the experi-
ment using streak assay (Buckling & Rainey, 2002) as a part of time- 
shift assay (see below).
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A time- shift assay approach (Buckling & Rainey, 2002; Nee, 1989) 
was used to determine whether bacteria and phages evolved adap-
tations and counteradaptations during the selection experiment. To 
this end, bacteria and phages were isolated from different sampling 
points during the experiment (transfers 1, 3 and 5). At every sam-
pling point, the contemporary bacteria were challenged to phages 
isolated from two transfers in the past and the future. If bacteria 
and phages are coevolving to become more resistant and infective, 
respectively, contemporary bacteria should be more resistant to 
phages isolated from the past versus the future. Phage infectiv-
ity and bacterial resistance were determined by streaking evolved 
bacterial colonies from time points 1, 3 and 5 across lines of phage 
that had previously been inoculated onto an LB agar plate. A similar 
method was used for bacteria isolated from transfers 3 and 5. A 
colony was defined as resistant if there was no inhibition of growth, 
o|_;ubv;b|-v7;=bm;7-vv;mvb|b;Őuo1h_uv|ķou]-mķ!-bm;ķş
Buckling, 2003; Buckling & Rainey, 2002).
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To test whether bacterial resistance to phages or antibiotics was as-
sociated with a fitness cost, evolved isolates were grown in LB media 
in the absence of phage or antibiotic at the end of the experiment. 
Evolved bacteria were thawed and replicated into fresh LB using a 
pin replicator (~0.2 μl transfer per pin, Boekel) as described above 
and grown for 24 hr at 37°C. All bacterial isolates were then repli-
cated into new 96- well plates containing LB. Following incubation 
at 37°C, growth was determined as optical density at 600 nm at 24 
and 48 hr postinoculation (Supporting information Figure S5). Cost 
of resistance was determined as the difference in bacterial maximum 
density or maximum growth rate of evolved relative to ancestral 
bacteria at 24- hr time point.
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Data were analysed using linear mixed models and factorial ANOVA 
approach where populations were set as subjects, isolation time 
point as a repeated factor and origin of isolation (planktonic vs. bio-
film) nested under replicate populations. Bacterial density or resist-
ance was explained by the presence of phage, presence of antibiotic 
and colony origin (from biofilm or planktonic phase of microcosms). 
The bacterial (CFU/ml and OD600 nm) and phage density (PFU/ml) 
data were log10- transformed prior to analysis to fulfil ANOVA as-
sumption of homogeneity of variance. When reporting results, the 
main effects and interactions of all factors are named before F- 
statistics and p- values.
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Both phage and antibiotic reduced total bacterial densities alone 
and in combination (treatment: F3, 16 = 62.742, p < 0.001; Figure 1). 
Antibiotic- alone treatment was most efficient at reducing bacterial 
densities compared to phage- alone treatment (antibiotic vs. phage: 
df = 16, p < 0.001) or phage- antibiotic (antibiotic vs. antibi-
otic + phage: df = 16, p < 0.001) treatments, which were equally ef-
fective at reducing bacterial densities (phage vs. antibiotic + phage: 
df = 16, p = 0.229). However, the dynamics of density reduction 
caused by phage- alone and phage- antibiotic treatments were very 
different: Phage- antibiotic treatment was initially equally effective 
at reducing bacterial densities as the antibiotic- alone treatment but 
lost its efficiency by the third sampling (Day 9) time point, and from 
then on, had comparable effect on bacterial densities as the phage- 
alone treatment (time × treatment: F12, 16 = 8.681, p < 0.001).
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We found that bacterial densities were much higher in plank-
tonic compared to biofilm populations on average (spatial dimension: 
F1, 32 = 335.932, p < 0.001). Also, the effect of phage and antibiotic 
was different for planktonic and biofilm populations (spatial dimen-
sion × treatment: F3, 32 = 9.17, p < 0.001). In planktonic populations, 
phage- alone had the weakest, and phageantibiotic intermediate 
and antibiotic- alone treatment the strongest negative effect on 
bacterial populations (treatment: F3, 16 = 99.471, p < 0.001; p < 0.05 
in all pairwise comparisons). Similar to total bacterial density anal-
ysis, phageantibiotic treatment was initially equally effective as 
the antibiotic- alone treatment but lost its efficiency by the third 
sampling (Day 9) time point (time × treatment: F12, 16 = 15.660, 
p < 0.001). In the case of biofilm populations, phage and antibiotic 
alone were equally effective at reducing bacterial densities on av-
erage, while phageantibiotic combination was the least effective 
(antibiotic × phage: F1, 32 = 335.932, p < 0.001). All treatments 
became more effective at reducing the densities of biofilm popu-
lations towards the end of the experiment (time: F4, 16 = 37.116, 
p < 0.001). However, this effect was less strong in phage treatments 
(time × treatment: F12, 16 = 6.603, p < 0.001). Together, these results 
suggest that phageantibiotic combination performed worse than 
antibiotic- only treatment and this difference became more pro-
nounced during the selection experiment.
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We found that the presence of antibiotics reduced the phage densi-
ties (antibiotic: F1, 8 = 11.090, p = 0.010), with combined antibiotic 
and phage treatment consistently having lower phage densities com-
pared to phage- only treatment. Phage densities increased slightly in 
the absence and decreased slightly in the presence of antibiotics 
during the experiment (phage × antibiotic: F4, 32 = 6.719 p < 0.001, 
Figure 1d). Together, these results show that antibiotics had indirect 
negative effect on phage densities during the selection experiment.
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Antibiotic resistance assays were conducted at the end of the se-
lection experiment. We found that evolved bacteria had highest 
relative growth in the presence of antibiotics when they had previ-
ously been exposed to antibiotics and phage during the selection 
experiment (phage × antibiotic: F1, 30 = 5.695, p = 0.017; Figure 2a). 
Exposure to antibiotics during the selection was also shown to be 
linked to higher relative growth in the presence on antibiotics (an-
tibiotic: F1, 30 = 8.398, p = 0.004). Prior exposure to phage selection 
also had a significant positive effect on bacterial growth in the pres-
ence of antibiotic (F1, 30 = 52.128, p < 0.001) indicative of potential 
cross- resistance. A significant interaction was also found between 
antibiotic and phage treatments on antibiotic resistance evolution 
(F1, 30 = 5.695, p = 0.017): Although both treatments had positive 
effects on the evolution of antibiotic resistance alone, the effect 
of phage selection was relatively stronger compared to antibiotic 
selection, and highest levels of resistance were observed in the 
phageantibiotic combination treatment. No significant difference 
was found between the growth of biofilm and planktonic bacterial 
populations in the presence of antibiotics (p > 0.05; Figure 2a).
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Previous exposure to a phage during the selection experiment in-
creased bacterial growth in the presence of ancestral phage rela-
tive to the control treatment (phage: F1, 30 = 21.576, p < 0.001; 
Figure 2b). In particular, evolved bacteria isolated from the biofilms 
grew significantly better in the presence of a phage compared to 
bacteria isolated from the planktonic phase across all treatments 
(spatial dimension: F1, 30 = 55.134, p < 0.001). Antibiotic selection 
alone did not affect the evolution of phage resistance (antibiotic: 
F1, 30 = 0.315, p = 0.574). However, we found a significant interac-
tion between spatial origin and phage treatment (spatial dimen-
sion × phage: F1, 30 = 9.535, p = 0.002), with phage selection having 
a larger effect on the resistance evolution of biofilm compared to 
planktonic populations. Together, these results suggest that phage 
resistance evolved to higher levels in bacterial biofilms during the 
selection experiment even in the absence of phage selection.
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We found no clear evidence for bacteriaphage coevolutionary dy-
namics in any of the treatments (the effect of phage isolation time 
point: F2, 34.6 = 0.738, p = 0.485). However, distinct changes in mean 
F I G U R E  2ՊBacterial resistance to antibiotic (a) and ancestral 
phage (b) measured at the end of the selection experiment. Panels 
(a) and (b) denote the growth of evolved bacteria in the presence 
of antibiotics, 3 μg/ml gentamycin and ancestral phage 14/1, 
respectively. Resistance indexes refer to the relative growth in 
the presence of antibiotic or phage compared to growth alone. 
Evolutionary treatment refers to different treatments during the 
selection experiment, and planktonic bacterial growth is shown in 
white and biofilm population growth in grey. Error bars show ±1 
standard error of mean
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phage resistance between different treatments and spatial origin 
were found. In contrast to endpoint measurement, phage resistance 
evolved to higher levels in planktonic compared to biofilm popula-
tions on average (spatial dimension: F1, 48.3 = 49.396, p < 0.001). 
Furthermore, antibiotic selection promoted the evolution of phage 
resistance more clearly in the planktonic bacterial populations 
(antibiotic × spatial dimension: F1, 48.3 = 31.981, p < 0.001). The 
rate and dynamics of phage resistance evolution also fluctuated in 
time depending on the treatment (time: F2, 47 = 10.403, p < 0.001): 
While phage resistance increased over time in combination treat-
ment, more fluctuations were observed in the phage- only treatment 
(Figure 3). Together, these results suggest that the study system was 
generally dominated by bacterial resistance evolution.
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We found that prior evolutionary history with phage or antibiotic 
did not affect bacterial maximum density relative to control treat-
ment (phage: F1, 15 = 2.884, p = 0.089; antibiotic: F1, 15 = 2.649, 
p = 0.104; Figure 4a). However, we found significant interaction 
between the two (phage × antibiotic: F1, 15 = 19.942, p < 0.001), 
which suggest that reduction in maximum density was observed 
in the antibiotic- only and phage- only but not in combination treat-
ment. While the spatial density had nonsignificant main effect, 
we found a significant interaction between the antibiotic treat-
ment and the spatial dimension (antibiotic × spatial dimension: F1, 
15 = 5.024, p = 0.025). This suggests that bacteria treated with an-
tibiotics suffered a larger reduction in maximum density when they 
were isolated from the planktonic phase of the microcosms. Cost 
of resistance was also measured in terms of reduction in maximum 
growth rate relative to ancestral bacterium (Figure 4b). Overall, all 
evolved populations showed clear reduction in their growth rate 
compared to ancestral bacterium (Figure 4b). However, this reduc-
tion was the lowest in the combination treatment (phage × anti-
biotic: F3, 43 = 14.43, p < 0.001), while spatial dimension had no 
significant effect on maximum growth rates. Together, these re-
sults suggest that evolution of resistance incurred relatively small 
cost, which was mainly observed with planktonic bacteria that had 
evolved in the presence of either antibiotic or the phage (maxi-
mum density), and in general, the cost of adaptation was the low-
est for bacteria that were exposed to combination treatment (both 
maximum density and growth rate).
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Here, we conducted a long- term evolutionary study to look phage
antibiotic synergy in spatially structured environment. Even though 
gentamycin and the phage exerted additive effects in the short- term 
preliminary experiment, we did not observe evidence of combined 
effects in our long- term selection experiment. In contrast, while 
phageantibiotic combination was equally good at controlling bacte-
rial growth as antibiotic- alone treatment in the beginning, it became 
 &! ƒՊRates of coevolution during 
the selection experiment for populations 
that evolved in planktonic (a and b) or 
biofilm phase (c and d) in the presence of 
phage (a and c) or antibiotic and phage 
(b and d). Each set of lines (from left to 
right) shows percentage of bacteria that 
are resistant to contemporary phage 
or phages isolated from two transfers 
in the past and in future. The slope of 
the line provides a measure of the rate 
of coevolution over each four- transfer 
period. Error bars show ±1 standard error 
of mean
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less effective from Day 9 due to rapid resistance evolution. Crucially, 
the level of resistance evolved the highest against both antibiotics 
and phages in the combination treatment indicative of generalized 
resistance evolution. This could be explained by biofilm- mediated 
resistance against both phage and antibiotic, phage- mediated cor-
related selection for increased antibiotic resistance, lack of cost of 
adaptation and weak phage infectivity evolution. Together, these re-
sults suggest that generalized resistance mechanisms could consid-
erably limit the efficacy of phageantibiotic treatments in the long 
term.
Even though we found evidence for additive phageantibiotic 
effects in our preliminary experiment, these were quickly lost during 
the selection experiment. Instead, phageantibiotic combination 
performed worse compared to antibiotic- alone treatment on aver-
age and was as equally effective as the antibiotic- alone treatment 
for just the first 6 days. This is in contrast with previous studies 
reporting beneficial effects of phageantibiotic combinations on 
Escherichia coli biofilms (Ryan, Alkawareek, Donnelly, & Gilmore, 
2012) and planktonic P. aeruginosa cultures (Torres- Barceló et al., 
2016). However, phageantibiotic effects are not always observed 
(Verma et al., 2009), which could be due to the specific phage spe-
cies and class of antibiotic as PAS often requires mechanistic com-
patibility between the two (Chan et al., 2016; Comeau et al., 2007; 
Kamal & Dennis, 2015). For example, it has recently been reported 
that associations between phage and gentamycin resistance are 
predominantly positive, while associations between phage and ci-
profloxacin resistance are mainly negative with natural and clinical 
E. colibvoѴ-|;vŐѴѴ;mķ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In our case, potential explanation for the loss of phageantibiotic 
effect is the evolution of biofilm- mediated generalized resistance 
mechanism provided by the spatial heterogeneity in the microcosms.
We found that bacteria evolved more resistant to both phage 
and antibiotic when exposed to selection by these agents individu-
ally, and in both cases, the resistance evolved higher within biofilm 
compared to planktonic populations. Crucially, resistance to both 
selective agents evolved the highest in the phageantibiotic com-
bination treatment where both planktonic and biofilm populations 
showed equally high levels of resistance. Relatively stronger resis-
tance evolution in combination treatment could also explain why 
phage population densities were consistently lower in the presence 
of antibiotics even though the number of host bacteria remained 
approximately the same between phage and phageantibiotic treat-
ments. The evolution of generalized resistance mechanism could be 
explained in various ways.
First, it is possible that selection by one selective agent led to 
cross- resistance against the other agent. For example, selection by 
one phage or antibiotic has been shown to lead to resistance to other 
phages and antibiotics, respectively (Davies & Davies, 2010; Hall, De 
Vos, Friman, Pirnay, & Buckling, 2012). In support for this, we found 
that phage selection alone led to a correlated increase in antibiotic 
resistance, while antibiotics had contrasting effect: no effect on the 
phage resistance of the biofilm but slight increase in the susceptibility 
of the planktonic bacterial populations to the phage. Positive correla-
tion between phage selection and antibiotic resistance is in contrast 
with previous studies showing an opposite effect where phage treat-
ment reduced the emergence of antibiotic resistance (Jalasvuori, 
Friman, Nieminen, Bamford, & Buckling, 2011; Zhang & Buckling, 
2012). One explanation for this discrepancy is that phageantibiotic 
synergies could be very specific to the given phage species and type 
of antibiotics, whereas antibiotic selection- mediated susceptibility to 
phages could have been driven by some degree of collateral sensitiv-
ity (Chan et al., 2016; Comeau et al., 2007; Kamal & Dennis, 2015).
Second, biofilms could have provided effective resistance mech-
anism against both phage and antibiotics (Abedon, 2017; Cochran 
et al., 2000; de Beer, 1997; de Beer et al., 1994; Labrie et al., 2010; 
Stewart & Costerton, 2001), and hence, selection for this trait could 
have been especially strong in the combination treatment. To explore 
the defensive function of biofilms in detail, we found that biofilm 
populations had higher levels of resistance compared to planktonic 
populations when exposed top selection by phage or antibiotic in-
dependently. Aminoglycoside antibiotics, including gentamycin, 
has been found to be less effective against biofilm than planktonic 
bacteria, largely due to decreased diffusion of antimicrobial agents 
through the biofilm matrix (Brockhurst, Buckling, & Rainey, 2006; 
Nouraldin et al., 2016). We found that control biofilm populations 
did not show clear resistance to phage or antibiotic. This suggests 
that biofilm growth per se did not make bacteria more resistant. 
Instead, biofilms likely evolved in terms of structure or other biofilm 
property and became more resistant to antibiotic and phage during 
the selection experiment. In support for this, it has been recently 
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 ƓՊRelative cost of resistance of evolved versus 
ancestral bacteria after 24 hr of growth in the absence of phage 
or antibiotic (based on OD600 nm-Ѵ;vőĺŐ-ő-bll0-1|;ub-Ѵ
density of evolved bacteria relative to ancestral bacterium (dashed 
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ancestral bacteria. In both panels, the dashed line represents the 
mean growth of ancestral bacterium. Evolutionary treatment 
refers to different treatments during the selection experiment, 
and planktonic bacterial growth is shown in white and biofilm 
population growth in grey. Error bars show ±1 standard error of 
mean
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reported that biofilms can protect E. coli against phage attack via 
two separate mechanisms: by inhibiting phage transport into the 
biofilm and by coating bacterial surface and binding phage particles, 
thereby preventing their attachment to the cell exterior (Vidakovic 
et al., 2018). We also found that both planktonic and biofilm popu-
lations evolved equally high levels of resistance in the combination 
treatment. This suggests that in addition to biofilms, also other re-
sistance mechanisms were important for bacterial fitness. Instead, 
enhanced biofilm growth could have led to more frequent sloughing 
of biofilm cell aggregates to the aquatic phase of the microcosms 
leading to increased resistance observed in planktonic population 
samples (Boles, Thoendel, & Singh, 2005). While these hypoth-
eses warrant more research, our data suggest that biofilms might 
play very important role for the evolution of generalized resistance 
mechanisms in P. aeruginosa.
Third, while evolution of resistance is often expected to lead to 
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Brockhurst, & Hochberg, 2006; Forde, Thompson, Holt, & Bohannan, 
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were only observed when bacteria had been exposed to either 
phage or antibiotic independently, whereas no cost was observed 
in the combination treatment or when the bacteria were isolated 
from the biofilm populations in general. Similar to previous studies 
conducted with antibiotics (Levin, Perrot, & Walker, 2000; Perron, 
Hall, & Buckling, 2010), it is possible that resistant bacteria were able 
to acquire compensatory mutations that counteracted the costs of 
resistance. Alternatively, developing resistance may have incurred 
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wider context, our results suggest that evolution of generalism might 
not always be limited by costs of adaptation (Kassen, 2002).
One neglected aspect of phageantibiotic combinations is the 
phages ability to coevolve more infective during the treatments. 
In contrast to previous, relatively short- term work with this system 
(Friman et al., 2016), we found no clear evidence for the coevolu-
tion between the phage and bacteria. Instead, the dynamics were 
mainly dictated by bacterial resistance evolution in all treatments. 
One explanation for this is that the spatial treatment (presence of 
beads) turned the coevolutionary dynamics asymmetrical by favour-
ing highly resistant biofilm populations in the microcosms (Drenkard, 
2003). If biofilms were able to completely block phage transport and 
access to receptors, no coevolution would be expected. However, 
this should have not prevented coevolution between the phage and 
bacteria in the planktonic populations. Lack of clear signs of coevo-
lutionary arms race dynamics is in line with a previous study, where 
coevolution was observed to be dominated by bacterial resistance 
(Brockhurst et al., 2006). One explanation for this is that heteroge-
neous environments can create permanent or ephemeral spatial ref-
];v=ou_ov|v0 Ѵblb|bm]r-u-vb|;7bvr;uv-Ѵ Ő-m-u7"lb|_ķƐƖƕƓĸ
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refreshing the resources in the microcosms, it is likely that beads 
provided permanent refuges from parasites. Continuous supply and 
migration of resistant bacteria from biofilms would have then likely 
increased the proportion of resistant bacteria also in planktonic pop-
ulations leading to nonobservable coevolutionary dynamics. It has 
also been shown that spatially structured soil environments could 
favour fluctuating coevolutionary dynamics and local phagebacteria 
adaptation in time (Gomez & Buckling, 2011), while spatial structure 
could decrease bacteriaphage encounter rates leading to slower 
rate of coevolution (Brockhurst et al., 2006). In future, it would be 
interesting to test directly how the absence and presence of spatial 
refugees affect the hostparasite coevolutionary dynamics. In the 
context of phage therapy, these results suggest that spatial environ-
ment might limit the phage ability to coevolve with the bacteria at 
the site of infection.
In conclusion, here we show that evolution of generalized resis-
tance mechanism can constrain the long- term efficiency of phagean-
tibiotic combinations in a spatially structured environment. However, 
it should be noted that we used only a single phage and antibiotic 
combination in our experiment and it is thus somewhat unclear how 
far these results could be generalized. Unravelling the genetic basis of 
generalized resistance mechanism will be one of the next targets of 
research. While phageantibiotic synergies could be driven by specific 
speciesantibiotic combinations, it is also possible that mutation basis 
of adaptation plays important role. For example, in case of collateral 
sensitivity and cross- resistance, it has been shown that the mutational 
basis of resistance to one antibiotic plays key role whether the sub-
sequent antibiotic will have negative or neutral effect for the bacte-
rial growth and that considerable variation can exists even between 
different replicate lines derived from the same selective environment 
(Barbosa et al., 2017). It is also likely that increasing the antibiotic con-
centration might change the outcome of phageantibiotic treatments. 
Here, we used a sublethal concentration of gentamycin, whereas a clin-
ically relevant concentration may have had a greater bactericidal effect 
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though phageantibiotic combinations have previously been proven 
to be more effective than either therapy alone, these effects should 
be studied on evolutionary timescale to acknowledge and understand 
the potential complications rising due rapid resistance evolution. Our 
results suggest that it is important to use combinations of phage and 
antibiotics that are sufficiently different by necessitating mechanistic 
trade- offs or substantial costs in order to prevent the rise of general-
ized resistance.
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